Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer (POP-RT)
Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial
Sponsor: Tata Memorial Centre
A NA clinical study on Prostate Cancer, this trial is ongoing. The trial is conducted by Tata Memorial Centre and has accumulated 11 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Mar 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Dec 2021 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Apr 2021 — Dec 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
-
Aug 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Aug 2018 [monthly]
Recruiting NA
First recorded
Nov 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tata Memorial Centre
For direct contact, visit the study record on ClinicalTrials.gov .